These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 46841)

  • 1. Quantification of mouse macrophage chemotaxis in vitro: role of C5 for the production of chemotactic activity.
    Snyderman R; Pike MC; McCarley D; Lang L
    Infect Immun; 1975 Mar; 11(3):488-92. PubMed ID: 46841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological activity of complement in vivo. Role of C5 in the accumulation of polymorphonuclear leukocytes in inflammatory exudates.
    Snyderman R; Phillips JK; Mergenhagen SE
    J Exp Med; 1971 Nov; 134(5):1131-43. PubMed ID: 5112201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathways.
    Gallin JI; Clark RA; Frank MM
    Clin Immunol Immunopathol; 1975 Jan; 3(3):334-46. PubMed ID: 1088938
    [No Abstract]   [Full Text] [Related]  

  • 4. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
    Clark RA; Klebanoff SJ
    J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depressed chemotactic responses in vitro of peritoneal macrophages from tumor-bearing mice.
    Stevenson MM; Meltzer MS
    J Natl Cancer Inst; 1976 Oct; 57(4):847-52. PubMed ID: 1003532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An inhibitor of macrophage chemotaxis produced by neoplasms.
    Snyderman R; Pike MC
    Science; 1976 Apr; 192(4237):370-2. PubMed ID: 946556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse mononuclear cell chemotaxis: description of system.
    Boetcher DA; Meltzer MS
    J Natl Cancer Inst; 1975 Mar; 54(3):795-9. PubMed ID: 1091744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bidirectional amplification of macrophage-lymphocyte interactions: enhanced lymphocyte activation factor production by activated adherent mouse peritoneal cells.
    Meltzer MS; Oppenheim JJ
    J Immunol; 1977 Jan; 118(1):77-82. PubMed ID: 137265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro production of colony-stimulating activity. I. Exposure of mouse peritoneal cells to endotoxin.
    Eaves AC; Bruce WR
    Cell Tissue Kinet; 1974 Jan; 7(1):19-30. PubMed ID: 4810547
    [No Abstract]   [Full Text] [Related]  

  • 10. Dissociation of macrophage accumulation and local chemotactic activity in delayed inflammatory sites.
    Jungi TW; McGregor DD
    Cell Immunol; 1979 Oct; 47(2):274-84. PubMed ID: 487449
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of chemotactic factors with human macrophages. Induction of transmembrane potential changes.
    Gallin EK; Gallin JI
    J Cell Biol; 1977 Oct; 75(1):277-89. PubMed ID: 410816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotaxis of resident, elicited and immunologically activated murine peritoneal macrophages.
    Staer AF; Rhodes JM; Bennedsen J; Olesen Larsen S
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):117-21. PubMed ID: 6880746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism for the inflammatory response in primate lungs. Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes.
    Kazmierowski JA; Gallin JI; Reynolds HY
    J Clin Invest; 1977 Feb; 59(2):273-81. PubMed ID: 401834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of macrophage chemotaxins in tumor cell cultures and comparison with lymphocyte-derived chemotactic factors.
    Meltzer MS; Stevenson MM; Leonard EJ
    Cancer Res; 1977 Mar; 37(3):721-5. PubMed ID: 837372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes.
    Snyderman R; Gewurz H; Mergenhagen SE
    J Exp Med; 1968 Aug; 128(2):259-75. PubMed ID: 4873021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO.
    WARD PA; COCHRANE CG; MUELLER-EBERHARD HJ
    J Exp Med; 1965 Aug; 122(2):327-46. PubMed ID: 14316948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of macrophages in the development of an immune response to typhoid bacterial polysaccharide Vi-antigen].
    Vysokodvorova RI
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):67-70. PubMed ID: 4471632
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of macrophages in the chemotactic response of polymorphonuclear leukocytes to bacterial lipopolysaccharides.
    Russo M
    Proc Soc Exp Biol Med; 1980 Jul; 164(3):326-30. PubMed ID: 7403101
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of serum-derived chemotactic factors and bacterial products on human neutrophil chemotaxis.
    Issekutz AC; Biggar WD
    Infect Immun; 1977 Jan; 15(1):212-20. PubMed ID: 64455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The abrogation of macrophage migration inhibition by pretreatment of immune exudate cells with anti-theta antibody and complement.
    Clinton BA; Magoc TJ; Aspinall RL
    J Immunol; 1974 May; 112(5):1741-6. PubMed ID: 4594414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.